Boule Diagnostics AB operates in the Electromedical equipment sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Boule Diagnostics AB with three other
companies in this sector in Sweden:
C-Rad AB
(2017
sales of 133.10 million Swedish Kronor [US$15.84 million]
),
Biotage AB
(748.15 million Swedish Kronor [US$89.02 million]
), and
Cellavision AB
(309.31 million Swedish Kronor [US$36.81 million]
of which 100%
was Automatic Microscopy).
Sales Analysis.
Boule Diagnostics AB reported sales of SEK 427.80 million (US$50.90 million)
for the
year ending
December of 2017.
This
represents
an
increase of 6.8%
versus 2016, when the company's sales were SEK 400.74 million.
Sales at Boule Diagnostics AB have increased during each of the previous five years
(and since 2012, sales have increased a total of 55%).